Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group.
Curran A, Monteiro P, Domingo P, Villar J, Imaz A, Martínez E, Fernández I, Knobel H, Podzamczer D, Iribarren JA, Peñaranda M, Crespo M; PIMOCS Study Group. Curran A, et al. Among authors: penaranda m. J Antimicrob Chemother. 2014 May;69(5):1390-6. doi: 10.1093/jac/dkt517. Epub 2014 Jan 10. J Antimicrob Chemother. 2014. PMID: 24415645
HTLV-1 infection in solid organ transplant donors and recipients in Spain.
de Mendoza C, Roc L, Benito R, Reina G, Ramos JM, Gómez C, Aguilera A, Rodríguez-Iglesias M, García-Costa J, Fernández-Alonso M, Soriano V; Spanish HTLV Network. de Mendoza C, et al. BMC Infect Dis. 2019 Aug 9;19(1):706. doi: 10.1186/s12879-019-4346-z. BMC Infect Dis. 2019. PMID: 31399112 Free PMC article.
[HIV-2 and HTLV-1/2 infections in Spain].
Treviño A, Soriano V; Grupo Español para el Estudio del VIH-2 y HTLV-1/2. Treviño A, et al. Med Clin (Barc). 2010 Jun 12;135(2):67-9. doi: 10.1016/j.medcli.2009.04.024. Epub 2009 Jun 27. Med Clin (Barc). 2010. PMID: 19560171 Spanish. No abstract available.
[Infection by HIV-2, HTLV and new human retroviruses in Spain].
Treviño A, Soriano V; Grupo Español para el Estudio del VIH-2/HTLV. Treviño A, et al. Med Clin (Barc). 2012 May 5;138(12):541-4. doi: 10.1016/j.medcli.2011.03.003. Epub 2011 May 11. Med Clin (Barc). 2012. PMID: 21565368 Spanish. No abstract available.
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.
Berenguer J, González J, Ribera E, Domingo P, Santos J, Miralles P, Angels Ribas M, Asensi V, Gimeno JL, Pérez-Molina JA, Terrón JA, Santamaría JM, Pedrol E; GESIDA 3903 Team. Berenguer J, et al. Clin Infect Dis. 2008 Oct 15;47(8):1083-92. doi: 10.1086/592114. Clin Infect Dis. 2008. PMID: 18781872 Clinical Trial.
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.
Mallolas J, Podzamczer D, Milinkovic A, Domingo P, Clotet B, Ribera E, Gutiérrez F, Knobel H, Cosin J, Ferrer E, Arranz JA, Roca V, Vidal F, Murillas J, Pich J, Pedrol E, Llibre JM, Dalmau D, García I, Aranda M, Cruceta A, Martínez E, Blanco JL, Lazzari Ed, Gatell JM; ATAZIP Study Group. Mallolas J, et al. J Acquir Immune Defic Syndr. 2009 May 1;51(1):29-36. doi: 10.1097/QAI.0b013e31819a226f. J Acquir Immune Defic Syndr. 2009. PMID: 19390327 Clinical Trial.
Drug resistance mutations in patients infected with HIV-2 living in Spain.
Treviño A, de Mendoza C, Caballero E, Rodríguez C, Parra P, Benito R, Cabezas T, Roc L, Aguilera A, Soriano V; HIV-2 Spanish Study Group. Treviño A, et al. J Antimicrob Chemother. 2011 Jul;66(7):1484-8. doi: 10.1093/jac/dkr164. Epub 2011 May 10. J Antimicrob Chemother. 2011. PMID: 21558334
130 results